Port Washington, New York – In an order issued on February 6, 2023, the JPML granted a request to consolidate cases involving allegations that hair relaxer products marketed by L’Oreal USA Inc. and others caused uterine, ovarian, endometrial, and other cancers in women.
Pursuant to the order, these cases, and others, will be consolidated before U.S. District Court Judge Mary M. Rowland in the Northern District of Illinois in Chicago as “All actions share common issues of fact regarding whether exposure to phthalates or other [endocrine-disrupting chemicals] causes injury to the reproductive system, whether and when defendants knew or should have known of the alleged risks posed by hair relaxer products, and whether defendants engaged in adequate testing and post-market surveillance.”
Lawsuits have been filed in federal courts in many states including those in New York, California, Tennessee, Ohio, and Georgia, and Parker Waichman LLP expects many more to be filed in the upcoming days and months.
Filing a Hair Relaxer Claim
Parker Waichman LLP represents hundreds of women for conditions believed to have been caused by the use of hair relaxer products.
If you or a loved one have used hair relaxers and been diagnosed with uterine cancer, or ovarian or endometrial cancer, you could be entitled to receive substantial monetary compensation from the manufacturers of these products.
Parker Waichman LLP helps those who have suffered from defective products receive full monetary compensation. If you or a loved one have been diagnosed with uterine, ovarian or endometrial cancer that they believe was caused by the use of hair relaxer products, please call our law firm at 1-800-968-7529 or visit our website at www.www.yourlawyer.com.
.svg){kind=small}
.avif)
.avif)
